Literature DB >> 15692148

Caveolin-1 in oncogenic transformation, cancer, and metastasis.

Terence M Williams1, Michael P Lisanti.   

Abstract

Caveolae are 50- to 100-nm omega-shaped invaginations of the plasma membrane that function as regulators of signal transduction. Caveolins are a class of oligomeric structural proteins that are both necessary and sufficient for caveolae formation. Interestingly, caveolin-1 has been implicated in the pathogenesis of oncogenic cell transformation, tumorigenesis, and metastasis. Here, we review the available experimental evidence (gleaned from cultured cells, animal models, and human tumor samples) that caveolin-1 (Cav-1) functions as a "tumor and/or metastasis modifier gene." Genetic evidence from the study of Cav-1(-/-) null mice and human breast cancer mutations [CAV-1 (P132L)] supports the idea that caveolin-1 normally functions as a negative regulator of cell transformation and mammary tumorigenesis. In contrast, caveolin-1 may function as a tumor promoter in prostate cancers. We discuss possible molecular mechanisms to explain these intriguing, seemingly opposing, findings. More specifically, caveolin-1 phosphorylation (at Tyr14 and Ser80) and mutations (P132L) may override or inactivate the growth inhibitory activity of the caveolin-scaffolding domain (residues 82-101).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15692148     DOI: 10.1152/ajpcell.00458.2004

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  200 in total

1.  Regulation of lung cancer cell migration and invasion by reactive oxygen species and caveolin-1.

Authors:  Sudjit Luanpitpong; Siera Jo Talbott; Yon Rojanasakul; Ubonthip Nimmannit; Varisa Pongrakhananon; Liying Wang; Pithi Chanvorachote
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

2.  Caveolin-1 upregulation contributes to c-Myc-induced high-grade prostatic intraepithelial neoplasia and prostate cancer.

Authors:  Guang Yang; Alexei A Goltsov; Chengzhen Ren; Shinji Kurosaka; Kohei Edamura; Richard Logothetis; Francesco J DeMayo; Patricia Troncoso; Jorge Blando; John DiGiovanni; Timothy C Thompson
Journal:  Mol Cancer Res       Date:  2011-12-05       Impact factor: 5.852

Review 3.  The role of RAD9 in tumorigenesis.

Authors:  Howard B Lieberman; Joshua D Bernstock; Constantinos G Broustas; Kevin M Hopkins; Corinne Leloup; Aiping Zhu
Journal:  J Mol Cell Biol       Date:  2011-02       Impact factor: 6.216

4.  Down-regulation of lysyl oxidase-like 2 (LOXL2) is associated with disease progression in lung adenocarcinomas.

Authors:  Ping Zhan; Xiao-Kun Shen; Qian Qian; Ji-Ping Zhu; Yu Zhang; Hai-Yan Xie; Chuen-Hua Xu; Ke-Ke Hao; Wei Hu; Ning Xia; Guo-Jun Lu; Li-Ke Yu
Journal:  Med Oncol       Date:  2011-04-26       Impact factor: 3.064

5.  Transcriptional repression of Caveolin-1 (CAV1) gene expression by GATA-6 in bladder smooth muscle hypertrophy in mice and human beings.

Authors:  Ettickan Boopathi; Cristiano Mendes Gomes; Robert Goldfarb; Mary John; Vittala Gopal Srinivasan; Jaber Alanzi; S Bruce Malkowicz; Hasmeena Kathuria; Stephen A Zderic; Alan J Wein; Samuel Chacko
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

6.  Probing the caveolin-1 P132L mutant: critical insights into its oligomeric behavior and structure.

Authors:  Monica D Rieth; Jinwoo Lee; Kerney Jebrell Glover
Journal:  Biochemistry       Date:  2012-04-25       Impact factor: 3.162

7.  Differential transcriptomic analysis of spontaneous lung tumors in B6C3F1 mice: comparison to human non-small cell lung cancer.

Authors:  Arun R Pandiri; Robert C Sills; Vincent Ziglioli; Thai-Vu T Ton; Hue-Hua L Hong; Stephanie A Lahousse; Kevin E Gerrish; Scott S Auerbach; Keith R Shockley; Pierre R Bushel; Shyamal D Peddada; Mark J Hoenerhoff
Journal:  Toxicol Pathol       Date:  2012-06-11       Impact factor: 1.902

8.  Exploring the interaction between the protein kinase A catalytic subunit and caveolin-1 scaffolding domain with shotgun scanning, oligomer complementation, NMR, and docking.

Authors:  Aron M Levin; John G Coroneus; Melanie J Cocco; Gregory A Weiss
Journal:  Protein Sci       Date:  2006-02-01       Impact factor: 6.725

9.  Caveolin-1 is Markedly Downregulated in Patients with Early-Stage Colorectal Cancer.

Authors:  Blanca Torrejón; Ion Cristóbal; Federico Rojo; Jesús García-Foncillas
Journal:  World J Surg       Date:  2017-10       Impact factor: 3.352

10.  Caveolin-1 promotes autoregulatory, Akt-mediated induction of cancer-promoting growth factors in prostate cancer cells.

Authors:  Likun Li; Chengzhen Ren; Guang Yang; Alexei A Goltsov; Ken-ichi Tabata; Timothy C Thompson
Journal:  Mol Cancer Res       Date:  2009-11-10       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.